FIELD : medicine.SUBSTANCE : invention relates to medicine, namely cardiology, and concerns the treatment of essential hypertension. For this purpose examine the changes of pro-and anti-inflammatory markers of blood : MCP-1, IP-10, vchSRB and IL-10 before treatment and 3 months after the start of treatment. When the MCP-1 indices change from 55.7?.6 pg/ml to 45.2?.4 pg/ml, IP-10 from 309.2?5.4 pg/ml to 321.6?9.1 pg/ml, vchSRB from 0.71 pg/ml to 0.63 pg/ml; and increasing the level of IL-10, antihypertensive therapy is assessed as effective.EFFECT : method provides the possibility of an objective assessment of the effectiveness of antihypertensive therapy and its timely individual correction.1 cl, 2 ex